Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Despite adverse event risk, anti psychotic polypharmacy has continued to rise
Despite adverse event risk, anti psychotic polypharmacy has continued to rise
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
The Brown University Psychopharmacology Update
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1002/pu.31298
Similar Items
Some anti‐psychotics associated with increased risk of pneumonia
Published: (2024)
Combination of SSRI and methylphenidate does not increase adverse event risk
Published: (2024)
Anti‐psychotic use in dementia patients linked to risk of numerous illnesses
Published: (2024)
Pharmacological treatments for psychotic depression
by: Y. W. Francis Lam
Published: (2024)
Switch from antipsychotic polypharmacy to monotherapy reduces side effects
Published: (2024)